Cite
Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns
MLA
Victoria Rollason, et al. Impact of Clinical Decision Support Guidelines on Therapeutic Drug Monitoring of Gentamicin in Newborns. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....56e328f5a945ac3f23a06fca431f7c77&authtype=sso&custid=ns315887.
APA
Victoria Rollason, Ana Coehlo, Regula Corbelli, Christophe Combescure, B. Guignard, Pascal Bonnabry, Jules Alexandre Desmeules, Klara M. Posfay-Barbe, Claudia Zaugg, Riccardo Pfister, Alain Gervaix, Caroline Fonzo-Christe, & Peter C. Rimensberger. (2014). Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns.
Chicago
Victoria Rollason, Ana Coehlo, Regula Corbelli, Christophe Combescure, B. Guignard, Pascal Bonnabry, Jules Alexandre Desmeules, et al. 2014. “Impact of Clinical Decision Support Guidelines on Therapeutic Drug Monitoring of Gentamicin in Newborns,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....56e328f5a945ac3f23a06fca431f7c77&authtype=sso&custid=ns315887.